Since Sp3 and Sp4 exhibit pro-oncogenic activities and are highly expressed in cancer cells, we are currently investigating the prognostic significance of Sp3 and Sp4 and comparing the results with previous studies on Sp1 to determine which Sp transcription factors (individual or combined) are the most accurate for patient prognosis. This evidence concerns the gene SP3 and cancer.